1. insights
  2. strategy catalyst
  3. health policy and advocacy
  4. investigative report raises questions about hims glp 1 compounding business
Strategist  | strategy-catalyst

Investigative report raises questions about Hims' GLP-1 compounding business

The Strategist lead image for web
Related Topics:
Health Policy and Advocacy
Relevant Roles:
Chief Strategy Officers

  • Hims & Hers stock fell by 8% following the publication of an investigative report into its GLP-1 drug compounding service.

    • The report was compiled by Hunterbrook Media, a fairly unique firm that publishes investigative stories about companies that its affiliated hedge fund, Hunterbrook Capital, invests in or short sells.